Bladder Cancer Coverage from Every Angle

Nicholas D. James, MB, PhD, on Bladder Cancer: MRI and Biopsy vs Resection for Cystoscopic Staging

Posted: Thursday, September 15, 2022

Nicholas D. James, MB, PhD, of London’s Institute of Cancer Research, discusses initial results from BladderPath, a study that compared MRI and biopsy vs surgical resection for diagnosis and staging of suspected muscle-invasive bladder cancer. The findings suggest that use of the image-guided pathway may halve the time to treatment with no apparent adverse effect on outcomes for patients with non–muscle-invasive disease.

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.